Naturally, NITE Will Help You Keep an Eye on NITE

05Sep10:32 amEST

Banks Breaking Rank...But is it Enough?

The Nasdaq is off to a particularly rough start this morning, off by roughly 1.4% as I write this and plenty of widespread selling below the surface in tech-related names. Naturally, bulls are giving the rotation game another attempt, seeing as it has been their calling card for a good while now. However, I am a bit skeptical as to whether the...

04Sep4:56 pmEST

Stock Market Recap 09/04/18 {Video}

The following video is a brief, condensed version of the Stock Market Recap which I present each evening to members of Market Chess Subscription Services. In the longer version, I offer tons of actionable trade ideas, educational content, and in-depth objective analysis across all markets. If you enjoy my videos and blog posts, then please...

04Sep3:00 pmEST

Bears Lacking Direction as Rotation Game Persists

The major averages are well off session lows as I write this, as extended leaders like AAPL AMZN SQ defy gravity and push higher yet. To be clear, all three of those name will indeed correct at some point. But as we have been reminding Members, the timing of it is uniquely difficult and we are probably better served to focus on sector rotations...

04Sep10:42 amEST

Nike Without the Noise

The latest decision by Nike to feature former NFL quarterback Colin Kaepernick as the face of the firm's 30th anniversary of it "Just Do It" campaign is creating quite the buzz this morning, with fierce arguments from both sides of the debate. Here at Market Chess, we have little interest in choosing political sides, not because we do not have...

02Sep7:25 amEST

Sunday Matinée at Market Chess Cinemas

Ed Wood (1994) pulls off the feat of trying to make a very good movie about a real-life terrible film director. This would be one of many famous collaborations between Director Tim Burton and star Johnny Depp. Memorable performances by Depp, Martin Landau and Sarah Jessica Parker make this black and white comedy-drama worth watching.

31Aug10:28 amEST

Summer is Going Out with a Bang, Literally

After an impressive earnings beat, the maker of iconic Smith & Wesson firearms, AOBC, is higher by more than 33% as I write this. In addition, peer RGR is up roughly 5.4%. Indeed, it has been a rather quiet couple of quarters for AOBC RGR as the Trump Administration is not perceived as a threat in any way to gun control, and the sleepy stock...

30Aug11:05 amEST

The Home Stretch for Baby Boomers

Father Time always wins. Despite astonishing advances in the medical field with respect to managing chronic diseases and other discoveries related to longevity, Father Time and Mother Nature are in very little danger of being defeated, just yet. And with the Baby Boomer generation now reaching a certain age, we simply must hone in on stocks...

29Aug4:00 pmEST

Stock Market Recap 08/29/18 {Video}

The following video is a brief, condensed version of the Stock Market Recap which I present each evening to members of Market Chess Subscription Services. In the longer version, I offer tons of actionable trade ideas, educational content, and in-depth objective analysis across all markets. If you enjoy my videos and blog posts, then please...

29Aug10:48 amEST

Stay ON the Weed

Given that TLRY is surging this morning after earnings and CGC quickly bouncing back from yesterday's overdue shakeout, marijuana stocks are impressing again as hot money traders are showing us they want to have more than just a one-night affair with them. Indeed, the MJ ETF for pot stocks reflects this, too, snapping back hard from...

28Aug2:39 pmEST

Naturally, NITE Will Help You Keep an Eye on NITE

Nightstar Therapeutics (NITE), a thinly-traded U.K.-based clinical-stage biotechnology company developing gene therapies for the treatment of currently untreatable retinal diseases, is surging back up to just below the key $22 breakout level. Since its IPO nearly a year ago, in September 2017, NITE has largely flown under-the-radar as the...